Pediatric Anxiety Treatment Research Study at Columbia Psychiatry
Company

Pediatric Anxiety Treatment Research Study at Columbia Psychiatry

Research Services 1051 Riverside Dr 31 employees
Employees
31
LinkedIn

Pediatric Anxiety Treatment Research Study at Columbia Psychiatry Overview

Headquarters
1051 Riverside Dr
Industry
Research Services
Employees
31
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Keywords
New York

About Pediatric Anxiety Treatment Research Study at Columbia Psychiatry

The Levine Lab and the Youth Treatment and Evaluation of Anxiety and Mood Program (Y-TEAM) at the Columbia University Medical Center are currently investigating how children and adolescents with anxiety respond to a selective serotonin reuptake inhibitor (SSRI) medication called sertraline (also known as Zoloft). The aim of this study is to understand how Zoloft works to help children and teenagers with anxiety and to find a biomarker that will determine medication response before treatment initiation. Study IRB number: #2019-0642

Compare Similar Companies to Pediatric Anxiety Treatment Research Study at Columbia Psychiatry

Global AI
It Services And It Consulting
Hopelab
Mental Health Care
Stanford Muslim Mental Health and Islamic Psychology Lab
Primary And Secondary Education
Department of Psychology at Penn State
Research Services
Columbia Build Lab
Venture Capital And Private Equity Principals
Columbia Justice Lab
Higher Education
Psych Lab Psychology Center
Hospitals And Health Care
Sustainable Engineering Lab at Columbia University
Utilities